Webinar
WHO PCV vaccination recommendations: 1p+1 dose schedules
Pneumococcal disease is a leading cause of death and serious illness in young children, especially in low- and middle-income countries. Since 2007, WHO has recommended the introduction of PCV into routine infant immunization programmes globally. As a result of PCV introduction, the incidence of invasive pneumococcal disease has dramatically decreased over time. PCV prevents severe diseases like meningitis, pneumonia, and sepsis, as well as milder conditions like otitis media.
WHO has recently released an updated PCV Position Paper to reflect new evidence from recent studies and real-world use, which will help countries in optimizing PCV product, schedule, and/or strategy to improve vaccine coverage, reduce costs, and ultimately save more children's lives, especially in resource-limited settings. The Position Paper is available here: https://iris.who.int/server/api/core/bitstreams/2cce44bc-af0b-4103-9048-54353f7d7ba1/content
This webinar presented and discussed over aspects related to the 2-dose schedule recommendation (1p+1) that will be useful to immunization related staff.
The presentation slides of this webinar session are available here.
Authors
-
Alejandro Ramirez Gonzalez
View profile | More articles -
Johanna Fihman
View profile | More articles - Maya M.V.X. van den Ent
- Nathalie Salagnac
Languages
Date
2025-11-19
Type
Webinar
Categories
- Programme management
Diseases
- Pneumococcal disease
Organisations
- World Health Organization (WHO)
TN-WEBINAR-2025
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Using digital technologies to enhance implementation of home- based records/ personal health records for maternal, newborn and child health | Laura Nic Lochlainn, Natschja Ratanaprayul, Hassan Sibomana, Pawan Kumar, Tomoya Yoshida, Annie Portela | 2025 | Webinar | English, French |
| Launch of "Operational Guidance: Multisectoral zero-dose strategies to improve routine immunization and other child outcomes" and accompanying case study compendium | Ibrahim Dadari, Desiree Stewart | 2025 | Webinar | English, Arabic, French, Spanish |
| Alternative methods for the validation of maternal and neonatal tetanus elimination (MNTE) in armed conflict and other access-constrained settings | Nasir Yusuf | 2025 | Webinar | English, French |
| Show me the data! Deep dive into understanding and optimizing vaccine wastage rates and resupply decisions | Laila Akhlaghi, Wendy Prosser | 2025 | Webinar | English |
| Ask Me Anything about EVM and cIP | Dan Brigden, Olamide Folorunso, Zainab Berry, Erida Nelaj | 2025 | Webinar | English |
| Dissemination for the targeted and selective strategies in measles and rubella vaccination campaigns: interim guidance | Oniovo Efe-Aluta, Santosh Gurung | 2025 | Webinar | English, French |
| Rabies elimination – the basics | Bernadette Abela, Frederic Lohr, Zsofia Hesketh, Juan Pablo Arguello Yepez, Kerenza Vlastou, Lunsungu Ngulube, Simbarashe Mabaya | 2025 | Webinar | English, French |
| Protection from birth: Expanding access to hepatitis B birth dose | Funmi Lesi, Sidy Ndiaye, Simbarashe Mabaya, Louise Henaff, Muhammad Shahid Jamil, Stephanie Shendale | 2025 | Webinar | English, French |
| Catch-Up Vaccination: Insights from 5 Big Catch-up Country Case Studies | Daniela Rodriguez, Ariel Higgins-Steele, Victoria Ngako, Chisom Obi-Jeff, Chinyere Okeke, Makki Ahmed, Stephen Mshana, Sheikh Al-Shoteri, Stephanie Shendale | 2025 | Webinar | English, Arabic, French |
| Introduction to Post Market Monitoring of cold chain equipment | Paul Mallins, Edda Magnus, Matt Morio, Danya Arif Siddiqi | 2025 | Webinar | English |
| Reaching Zero-Dose Children: Insights from Six Implementation Research Studies | Daniela Rodriguez, Collins Buh, Dora Dadzie, Sylvestre Bemanana, Dziko Chatata, Lucia Vieira, Rutaba Syed, Jane Dzoole, Sylvester Maleghemi | 2025 | Webinar | English, French |
| WHO PCV vaccination recommendations: 1p+1 dose schedules | Alejandro Ramirez Gonzalez, Johanna Fihman, Maya M.V.X. van den Ent, Nathalie Salagnac | 2025 | Webinar | English, French |
